Reporting owner · CIK 0002071923

Denton John Russel

SEC Form 4 history for the last 180 days across 1 company, 1 transaction and 1 filing.

SRSee RemarksCaris Life Sciences, Inc.
Open-market transaction mix0% buys0 buys · 1 sale

Period: Last 180 days

Trade dates in this period: Sep 22, 2026 – Sep 22, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings1Form 4 records
Buying$00 purchases
Selling$239k1 sale
Net value−$239kBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
Denton John Russel transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
CAICaris Life Sciences, Inc.
SR
SR
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$239kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

The insider reported a sale at Caris Life Sciences, Inc. on Sep 22, 2026 valued at $238,626.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Monthly open-market activity

Last 1 reported month · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Sep 202601$0$238,626−$238,626

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$239k
Median P/S size$239k
Direct1
Indirect0
Sep 22, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Associated companies

Counts cover all available history, including outside the summary period

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in the last 180 days

A 90-day purchase return requires an open-market buy. None is recorded in the last 180 days. Purchases filed earlier are outside the visible history and are not included.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

1 observations · Sep 22, 2026 – Sep 22, 2026. Window ends at the latest available report, not today.

Selected observation · Sep 22, 2026174,855 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Sep 22, 2026174,855Sep 23, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Denton John Russel Insider Activity FAQ

SEC Form 4 context

Who is Denton John Russel?

Denton John Russel is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002071923.

Which companies has Denton John Russel reported transactions for?

Caris Life Sciences, Inc.

When was Denton John Russel's latest insider buy?

No open-market insider purchase is recorded in the last 180 days. Earlier filings are outside the visible history.

When was Denton John Russel's latest insider sale?

The insider reported a sale at Caris Life Sciences, Inc. on Sep 22, 2026 valued at $238,626.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.